Skip to main content
Top
Published in: Journal of Neurology 1/2024

Open Access 12-09-2023 | Creutzfeldt-Jakob Disease | Original Communication

MRI abnormalities in Creutzfeldt–Jakob disease and other rapidly progressive dementia

Authors: Renzo Manara, Federica Fragiacomo, Anna Ladogana, Luana Vaianella, Giulia Camporese, Giovanni Zorzi, Sabrina Vicinanza, Gianluigi Zanusso, Maurizio Pocchiari, Annachiara Cagnin

Published in: Journal of Neurology | Issue 1/2024

Login to get access

Abstract

Objective

To investigate brain MRI abnormalities in a cohort of patients with rapidly progressive dementia (RPD) with and without a diagnosis of Creutzfeldt–Jakob disease (CJD).

Methods

One hundred and seven patients with diagnosis of prion disease (60 with definite sCJD, 33 with probable sCJD and 14 with genetic prion disease) and 40 non-prion related RPD patients (npRPD) underwent brain MRI including DWI and FLAIR. MRIs were evaluated with a semiquantitative rating score, which separately considered abnormal signal extent and intensity in 22 brain regions. Clinical findings at onset, disease duration, cerebrospinal-fluid 14-3-3 and t-tau protein levels, and EEG data were recorded.

Results

Among patients with definite/probable diagnosis of CJD or genetic prion disease, 2/107 had normal DWI-MRI: in one patient a 2-months follow-up DWI-MRI showed CJD-related changes while the other had autopsy-proven CJD despite no DWI abnormalities 282 days after clinical onset. CJD-related cortical changes were detected in all lobes and involvement of thalamus was common. In the npRPD groups, 6/40 patients showed DWI alterations that clustered in three different patterns: (1) minimal/doubtful signal alterations (limbic encephalitis, dementia with Lewy bodies); (2) clearly suggestive of alternative diagnoses (status epilepticus, Wernicke or metabolic encephalopathy); (3) highly suggestive of CJD (mitochondrial disease), though cortical swelling let exclude CJD.

Conclusions

In the diagnostic work-up of RPD, negative/doubtful DWI makes CJD diagnosis rather unlikely, while specific DWI patterns help differentiating CJD from alternative diagnoses. The pulvinar sign is not exclusive of the variant form.
Appendix
Available only for authorised users
Literature
2.
go back to reference Tagliapietra M, Zanusso G, Fiorini M et al (2013) Accuracy of diagnostic criteria for sporadic Creutzfeldt–Jakob disease among rapidly progressive dementia. J Alzheimers Dis 34:231–238CrossRefPubMed Tagliapietra M, Zanusso G, Fiorini M et al (2013) Accuracy of diagnostic criteria for sporadic Creutzfeldt–Jakob disease among rapidly progressive dementia. J Alzheimers Dis 34:231–238CrossRefPubMed
3.
go back to reference Zerr I, Hermann P (2018) Diagnostic challenges in rapidly progressive dementia. Expert Rev Neurother 18:41–56CrossRef Zerr I, Hermann P (2018) Diagnostic challenges in rapidly progressive dementia. Expert Rev Neurother 18:41–56CrossRef
4.
go back to reference Day GS, Tang-Wai DF (2014) When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia. Neurodegener Dis Manag 4:41–56CrossRefPubMed Day GS, Tang-Wai DF (2014) When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia. Neurodegener Dis Manag 4:41–56CrossRefPubMed
7.
go back to reference Orrú CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B (2015) Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio 6:e02451-e2514CrossRefPubMedPubMedCentral Orrú CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B (2015) Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio 6:e02451-e2514CrossRefPubMedPubMedCentral
8.
go back to reference Bongianni M, Orru C, Groveman BR et al (2017) Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol 74:155–162CrossRefPubMed Bongianni M, Orru C, Groveman BR et al (2017) Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol 74:155–162CrossRefPubMed
9.
go back to reference Hermann P, Laux M, Glatzel M et al (2018) Validation and utilization of amended diagnostic criteria in Creutzfeldt–Jakob disease surveillance. Neurology 91:e331–e338CrossRefPubMed Hermann P, Laux M, Glatzel M et al (2018) Validation and utilization of amended diagnostic criteria in Creutzfeldt–Jakob disease surveillance. Neurology 91:e331–e338CrossRefPubMed
10.
go back to reference Hermann P, Appleby B, Brandel JP et al (2021) Biomarkers and diagnostic guidelines for sporadic Creutzfeldt–Jakob disease. Lancet Neurol 20:235–246CrossRefPubMedPubMedCentral Hermann P, Appleby B, Brandel JP et al (2021) Biomarkers and diagnostic guidelines for sporadic Creutzfeldt–Jakob disease. Lancet Neurol 20:235–246CrossRefPubMedPubMedCentral
11.
12.
go back to reference Bizzi A, Pascuzzo R, Blevins J et al (2020) Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging. JAMA Neurol 77:1141–1149CrossRefPubMed Bizzi A, Pascuzzo R, Blevins J et al (2020) Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging. JAMA Neurol 77:1141–1149CrossRefPubMed
13.
go back to reference Rudge P, Hyare H, Green A, Collinge J, Mead S (2018) Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry 89:461–466CrossRefPubMed Rudge P, Hyare H, Green A, Collinge J, Mead S (2018) Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry 89:461–466CrossRefPubMed
14.
go back to reference Vitali P, Maccagnano E, Caverzasi E et al (2011) Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711–1719CrossRefPubMedPubMedCentral Vitali P, Maccagnano E, Caverzasi E et al (2011) Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711–1719CrossRefPubMedPubMedCentral
15.
go back to reference Hirai T, Korogi Y, Yoshizumi K, Shigematsu Y, Sugahara T, Takahashi M (2000) Limbic lobe of the human brain: evaluation with turbo fluid-attenuated inversion-recovery MR imaging. Radiology 215:470–475CrossRefPubMed Hirai T, Korogi Y, Yoshizumi K, Shigematsu Y, Sugahara T, Takahashi M (2000) Limbic lobe of the human brain: evaluation with turbo fluid-attenuated inversion-recovery MR imaging. Radiology 215:470–475CrossRefPubMed
16.
go back to reference Baiardi S, Magherini A, Capellari S et al (2017) Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type). J Neurol Neurosurg Psychiatry 88:764–772CrossRefPubMed Baiardi S, Magherini A, Capellari S et al (2017) Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type). J Neurol Neurosurg Psychiatry 88:764–772CrossRefPubMed
17.
go back to reference Meissner B, Kallenberg K, Sanchez-Juan P et al (2009) MRI lesion profiles in sporadic Creutzfeldt–Jakob disease. Neurology 72:1994–2001CrossRefPubMed Meissner B, Kallenberg K, Sanchez-Juan P et al (2009) MRI lesion profiles in sporadic Creutzfeldt–Jakob disease. Neurology 72:1994–2001CrossRefPubMed
18.
go back to reference Pascuzzo R, Oxtoby NP, Young AL et al (2020) Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt–Jakob disease. Acta Neuropathol 140:169–181CrossRefPubMedPubMedCentral Pascuzzo R, Oxtoby NP, Young AL et al (2020) Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt–Jakob disease. Acta Neuropathol 140:169–181CrossRefPubMedPubMedCentral
19.
go back to reference Bizzi A, Pascuzzo R, Blevins J et al (2021) Subtype diagnosis of sporadic Creutzfeldt–Jakob disease with diffusion magnetic resonance imaging. Ann Neurol 89:560–572CrossRefPubMed Bizzi A, Pascuzzo R, Blevins J et al (2021) Subtype diagnosis of sporadic Creutzfeldt–Jakob disease with diffusion magnetic resonance imaging. Ann Neurol 89:560–572CrossRefPubMed
21.
go back to reference Young GS, Geschwind MD, Fischbein NJ et al (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt–Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26:1551–1562PubMedPubMedCentral Young GS, Geschwind MD, Fischbein NJ et al (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt–Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26:1551–1562PubMedPubMedCentral
22.
go back to reference Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S (2002) Conspicuity and evolution of lesions in Creutzfeldt–Jakob disease at diffusion-weighted imaging. AJNR Am J Neuroradiol 23:1164–1172PubMedPubMedCentral Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S (2002) Conspicuity and evolution of lesions in Creutzfeldt–Jakob disease at diffusion-weighted imaging. AJNR Am J Neuroradiol 23:1164–1172PubMedPubMedCentral
23.
go back to reference Zanusso G, Camporese G, Ferrari S et al (2016) Long-term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt–Jakob disease. Ann Neurol 80:629–632CrossRefPubMed Zanusso G, Camporese G, Ferrari S et al (2016) Long-term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt–Jakob disease. Ann Neurol 80:629–632CrossRefPubMed
24.
go back to reference Satoh K, Nakaoke R, Nishiura Y et al (2011) Early detection of sporadic CJD by diffusion-weighted MRI before the onset of symptoms. J Neurol Neurosurg Psychiatry 82(2):942–943CrossRefPubMed Satoh K, Nakaoke R, Nishiura Y et al (2011) Early detection of sporadic CJD by diffusion-weighted MRI before the onset of symptoms. J Neurol Neurosurg Psychiatry 82(2):942–943CrossRefPubMed
Metadata
Title
MRI abnormalities in Creutzfeldt–Jakob disease and other rapidly progressive dementia
Authors
Renzo Manara
Federica Fragiacomo
Anna Ladogana
Luana Vaianella
Giulia Camporese
Giovanni Zorzi
Sabrina Vicinanza
Gianluigi Zanusso
Maurizio Pocchiari
Annachiara Cagnin
Publication date
12-09-2023
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 1/2024
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-023-11962-1

Other articles of this Issue 1/2024

Journal of Neurology 1/2024 Go to the issue

Neurological Update

Advances in leukodystrophies